Literature DB >> 19809787

Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature.

Hakan Gümüş1, Hüseyin Per, Sefer Kumandaş, Ali Yikilmaz.   

Abstract

Reversible posterior leukoencephalopathy syndrome (RPLS) is recently described disorder with typical radiological findings in the posterior regions of the cerebral hemisphere and cerebellum. Its clinical symptoms include headache, decreased alertness, mental abnormalities, such as confusion, diminished spontaneity of speech, and changed behavior ranging from drowsiness to stupor, seizures, vomiting and abnormalities of visual perception like cortical blindness. RPLS is caused by various heterogeneous factors, the commonest being hypertension, followed by non-hypertensive causes such as eclampsia, renal diseases and immunosuppressive therapy. We presented nine patients with RPLS who had primary diagnoses such as acute post-streptococcal glomerulonephritis, idiopathic hypertension, the performing of intravenous immunoglobulin for infection with crescentic glomerulonephritis, erythrocyte transfusion for severe iron deficiency, L: -asparaginase treatment for acute lymphoblastic leukemia and performing of granulocyte-colony stimulating factor for ulcerative colitis due to neutropenia. Early recognition of RPLS as complication during different diseases and therapy in childhood may facilitate precise diagnosis and appropriate treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19809787     DOI: 10.1007/s10072-009-0158-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  39 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

2.  Recurrent reversible cerebral edema after long term immunosuppression with tacrolimus.

Authors:  Manuela Reinohs; Torsten Straube; Petra Baum; Jörg Berrouschot; Armin Wagner
Journal:  J Neurol       Date:  2002-06       Impact factor: 4.849

3.  The reversible posterior cerebral edema syndrome.

Authors:  W P Dillon; H Rowley
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

4.  Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings.

Authors:  R Bakshi; V E Bates; L L Mechtler; P R Kinkel; W R Kinkel
Journal:  Epilepsia       Date:  1998-03       Impact factor: 5.864

5.  Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients.

Authors:  R Bakshi; Z A Shaikh; V E Bates; P R Kinkel
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

6.  Posterior leukoencephalopathy syndrome in poststreptococcal acute glomerulonephritis.

Authors:  A Soylu; S Kavukçu; M Türkmen; Y Akbaş
Journal:  Pediatr Nephrol       Date:  2001-07       Impact factor: 3.714

7.  Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging.

Authors:  P Mukherjee; R C McKinstry
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

8.  Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia.

Authors:  P W Schaefer; F S Buonanno; R G Gonzalez; L H Schwamm
Journal:  Stroke       Date:  1997-05       Impact factor: 7.914

Review 9.  Magnetic resonance imaging in Posterior Reversible Encephalopathy Syndrome: report of three cases and review of literature.

Authors:  Vanina Finocchi; Alessandro Bozzao; Michela Bonamini; Michele Ferrante; Andrea Romano; Claudio Colonnese; Luigi Maria Fantozzi
Journal:  Arch Gynecol Obstet       Date:  2004-10-09       Impact factor: 2.344

10.  The role of tumor lysis in reversible posterior leukoencephalopathy syndrome.

Authors:  Emiko Kaito; Satoshi Terae; Ryoji Kobayashi; Kohsuke Kudo; Khin Khin Tha; Kazuo Miyasaka
Journal:  Pediatr Radiol       Date:  2005-03-09
View more
  21 in total

1.  Posterior reversible encephalopathy syndrome with colitis in a patient treated with panitumumab.

Authors:  Céline Blaye; Xavier Buy; Marine Gross-Goupil; Didier Vincent; Claire Jamet; Paul Sargos; Stéphane Culine; Guilhem Roubaud
Journal:  Ther Adv Drug Saf       Date:  2017-01-16

2.  Imaging Patterns and Outcome of Posterior Reversible Encephalopathy Syndrome During Childhood Cancer Treatment.

Authors:  Raja B Khan; Zsila S Sadighi; Jennifer Zabrowski; Amar Gajjar; Sima Jeha
Journal:  Pediatr Blood Cancer       Date:  2015-10-15       Impact factor: 3.167

3.  Temporary Visual Loss Due to Posterior Reversible Encephalopathy Syndrome in the Case of an End-Stage Renal Disease Patient.

Authors:  Michael Chia-Yen Chou; Chia-Yi Lee; Shih-Chun Chao
Journal:  Neuroophthalmology       Date:  2017-05-30

4.  Posterior reversible encephalopathy syndrome in a case of postoperative spinal extradural haematoma: case report and review of literature.

Authors:  Chittur Viswanathan Gopalakrishnan; Vazhayil Vikas; Suresh Nair
Journal:  Asian Spine J       Date:  2011-03-02

5.  Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A case report and review of the literature.

Authors:  Pingping Zhang; Xiaofeng Li; Yating Li; Jing Wang; Huasong Zeng; Xiaofeng Zeng
Journal:  Biomed Rep       Date:  2014-11-07

6.  Reversible posterior leukoencephalopathy induced by carboplatin and etoposide.

Authors:  S A Ryan; P Maceneaney; S P O'Reilly; E J Moylan; D G Power
Journal:  Med Oncol       Date:  2011-03-10       Impact factor: 3.064

Review 7.  Approach to Persistent Microscopic Hematuria in Children.

Authors:  Mahmoud Kallash; Michelle N Rheault
Journal:  Kidney360       Date:  2020-07-10

Review 8.  Colony stimulating factors in the nervous system.

Authors:  Violeta Chitu; Fabrizio Biundo; E Richard Stanley
Journal:  Semin Immunol       Date:  2021-11-04       Impact factor: 11.130

9.  Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient with Opioid Use Disorder.

Authors:  Terence Tumenta; Samuel Adeyemo; Oluwatoyin Oladeji; Oluwole Jegede; Bordes Laurent; Tolu Olupona
Journal:  Case Rep Psychiatry       Date:  2021-06-16

10.  Congenital adrenal hyperplasia and brain magnetic resonance imaging abnormalities.

Authors:  Younes-Mhenni Samia; Kamoun Mahdi; Zantour Baha; Jerbi-Ommezine Saida; Sfar Mohamed Tahar; Sfar Mohamed Habib
Journal:  Clin Pediatr Endocrinol       Date:  2010-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.